Abstract
This issue reports the methods of twelve in vitro assays currently being used to screen potential chemopreventive agents for activity. These assays provide quantitative data to help determine the efficacy and prioritize agents for further development in whole animal screening. It is essential that such in vitro assays provide accurate, consistent, and relevant data to identify and prioritize agents with the most promise to prevent human cancer. The twelve assays presented in this volume are currently providing such data to the National Cancer Institute's Chemoprevention Program.
References
Kelloff GJ, Boone CW, Malone WF, Steele VE (1992). Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ (eds), Cancer chemoprevention. Boca Raton: CRC Press, pp 41–56.
Kelloff GJ, Boone CW, Malone WF, Steele VE (1993). Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. Basic Life Sci 61: 373–386.
Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994). Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54: 2015S–2024S.
Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC (1994). Chemopreventive drug development: Perspectives and progress. Cancer Epidemiol Biomarkers Prev 3: 85–98.
Greenwald P, Kelloff G, Burch-Whitman C, Kramer BS (1995). Chemoprevention. CA Cancer J Clin 45: 31–49.
Steele VE, Sharma S, Mehta R, Elmore E, Redpath JL, Rudd C, Baghari D, Sigman CC, Kelloff GJ (1996). Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cellular Biochem 26 (suppl): 23–46.
Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich MJ, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW, Kelloff GJ (1994). Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI Chemoprevention Drug Development Program. J Cellular Biochem 20 (suppl): 32–54.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steele, V.E., Boone, C.W., Lubet, R.A. et al. Rationale for the selection and use of in vitro assays to screen for chemopreventive agents. Methods Cell Sci 19, 1–2 (1997). https://doi.org/10.1023/A:1009772307902
Issue Date:
DOI: https://doi.org/10.1023/A:1009772307902